MEDICUS PHARMA LTD (MDCX) Stock Income Statement
NASDAQ:MDCX - Nasdaq - CA58471K2020 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 11.18M | 2.66M | 978.40K | 141.70K | 88.10K | |||
| Research and Development | 3.53M | 193.60K | 646.40K | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 7.65M | 2.46M | 332.00K | 141.70K | 88.10K | |||
| Operating Income | -11.18M | -2.66M | -978.40K | -141.70K | -88.10K | |||
| Interest Income/Expense | 25.40K | -584.80K | -526.80K | N/A | N/A | |||
| Other Income/Expense | N/A | N/A | -187.10K | N/A | N/A | |||
| Non Recurring Items | 0.00 | -2.07M | 0.00 | N/A | N/A | |||
| Income Before Taxes | -11.16M | -5.31M | -1.69M | -141.70K | -88.10K | |||
| Net Income | -11.16M | -5.31M | -1.69M | -141.70K | -88.10K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.16 | -1.53 | -0.90 | -0.04 | -0.27 | |||
| Non GAAP EPS | -2.01 | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD